ARCHIVES

Major Changes Being Considered By NCI For FCRA

This article is from The Cancer Letter archive.

Vol. 04 No. 15 | April 14, 1978

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

March 15, 2002

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

ASCO, NCCS form cancer quality alliance.

November 11, 2005

DCPC Board Oks Concept For Three New Grant Programs, Three Contracts

May 22, 1987

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002